Desjardins Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Desjardins Global Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.67M	Buy	32,615 +156	+0.5%	+$8.19K	0.18%	135
2023 Q3	$1.88M	Buy	32,459 +1,111	+4%	+$68.1K	0.21%	106
2023 Q2	$2M	Buy	31,348 +5,189	+20%	+$348K	0.23%	94
2023 Q1	$1.81M	Buy	26,159 +6,215	+31%	+$438K	0.23%	95
2022 Q4	$1.44M	Sell	19,944 -2,451	-11%	-$185K	0.23%	99
2022 Q3	$1.59M	Buy	22,395 +444	+2%	+$32.2K	0.2%	104
2022 Q2	$1.69M	Buy	21,951 +5,617	+34%	+$428K	0.22%	105
2022 Q1	$1.19M	Sell	16,334 -2,504	-13%	-$168K	0.1%	181
2021 Q4	$1.17M	Buy	+18,838	New	+$1.11M	0.1%	186

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Desjardins Global Asset Management's BMY Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.48% in Q4 2023, buying an estimated $8.19K and bringing the position to 32,615 shares worth $1.67M. The position accounts for 0.18% of the portfolio, ranked #135.

Desjardins Global Asset Management first reported a position in BMY in Q4 2021 and has held it in 9 quarters since. The position peaked at $2M in Q2 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Desjardins Global Asset Management held 32,615 shares of Bristol-Myers Squibb worth $1.67M as of Q4 2023.
Desjardins Global Asset Management bought 156 Bristol-Myers Squibb shares in Q4 2023, an estimated $8.19K.
Bristol-Myers Squibb made up 0.18% of Desjardins Global Asset Management's portfolio in Q4 2023, its #135 holding.
Desjardins Global Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Bristol-Myers Squibb position peaked at $2M in Q2 2023.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.